BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3409548)

  • 1. Impaired release of natural killer cytotoxic factor in patients with primary Sjögren's syndrome.
    Pedersen BK; Oxholm P
    Clin Exp Immunol; 1988 May; 72(2):299-302. PubMed ID: 3409548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 2 augmentation of the defective natural killer cell activity in patients with primary Sjögren's syndrome.
    Pedersen BK; Oxholm P; Manthorpe R; Andersen V
    Clin Exp Immunol; 1986 Jan; 63(1):1-7. PubMed ID: 3485480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired indomethacin-boosting of the defective natural killer cell activity in patients with primary Sjögren's syndrome.
    Pedersen BK; Oxholm P; Manthorpe R; Andersen V
    Scand J Rheumatol Suppl; 1986; 61():135-8. PubMed ID: 3473621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL 2.
    Bonavida B; Katz J; Gottlieb M
    J Immunol; 1986 Aug; 137(4):1157-63. PubMed ID: 3488345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of peripheral natural killer cells in primary Sjögren's syndrome: impaired NK cell activity and low NK cell number.
    Izumi Y; Ida H; Huang M; Iwanaga N; Tanaka F; Aratake K; Arima K; Tamai M; Kamachi M; Nakamura H; Origuchi T; Kawakami A; Anderson P; Eguchi K
    J Lab Clin Med; 2006 May; 147(5):242-9. PubMed ID: 16697772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the lethal hit stage of natural killer cell-mediated cytotoxicity. I. Both phorbol ester and ionophore are required for release of natural killer cytotoxic factors (NKCF), suggesting a role for protein kinase C activity.
    Graves SS; Bramhall J; Bonavida B
    J Immunol; 1986 Sep; 137(6):1977-84. PubMed ID: 2427588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
    J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of altered membrane structure on NK cell-mediated cytotoxicity. III. Decreased susceptibility to natural killer cytotoxic factor (NKCF) and suppression of NKCF release by membrane rigidification.
    Roozemond RC; Mevissen M; Urli DC; Bonavida B
    J Immunol; 1987 Sep; 139(5):1739-46. PubMed ID: 3624869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the mechanism of natural killer cell-mediated cytotoxicity. V. Lack of NK specificity at the level of induction of natural killer cytotoxic factors in cultures of human, murine, or rat effector cells stimulated with mycoplasma-free cell lines.
    Wright SC; Bonavida B
    J Immunol; 1984 Dec; 133(6):3415-23. PubMed ID: 6491292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinction of partially purified human natural killer cytotoxic factor from recombinant human tumor necrosis factor and recombinant human lymphotoxin.
    Bialas T; Kolitz J; Levi E; Polivka A; Oez S; Miller G; Welte K
    Cancer Res; 1988 Feb; 48(4):891-8. PubMed ID: 3257413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cytotoxic factor induction by K562 cells in patients with advanced cancer: correlation with production of interferon.
    Steinhauer EH; Doyle AT; Reed J; Kadish AS
    J Natl Cancer Inst; 1985 Dec; 75(6):1017-23. PubMed ID: 2415742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cell-mediated immunity in patients with Sjogren's syndrome].
    Krejsek J; Slezák R; Kopecký O; Vokurková D; Loudová M; Derner V
    Cas Lek Cesk; 1997 Jan; 136(2):44-7. PubMed ID: 9147852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.
    Wright SC; Weitzen ML; Kahle R; Granger GA; Bonavida B
    J Immunol; 1983 May; 130(5):2479-83. PubMed ID: 6833762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of human natural killer soluble cytotoxic factors (NKCF) derived from NK-enriched lymphocyte populations: specificity of generation and killing.
    Farram E; Targan SR
    J Immunol; 1983 Mar; 130(3):1252-6. PubMed ID: 6822733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the mechanism of natural killer cell-mediated cytotoxicity. VII. functional comparison of human natural killer cytotoxic factors with recombinant lymphotoxin and tumor necrosis factor.
    Wright SC; Bonavida B
    J Immunol; 1987 Mar; 138(6):1791-8. PubMed ID: 3493288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of rat natural killer cytotoxic factor (NKCF) produced by rat NK cell lines and the production of a murine monoclonal antibody that neutralizes NKCF.
    Ortaldo JR; Winkler-Pickett R; Morgan AC; Woodhouse C; Kantor R; Reynolds CW
    J Immunol; 1987 Nov; 139(9):3159-65. PubMed ID: 3668253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the mechanism of the human natural killer cell lethal hit: analysis of the mechanism of protease inhibition of the lethal hit.
    Hiserodt JC; Britvan L; Targan SR
    J Immunol; 1983 Dec; 131(6):2705-9. PubMed ID: 6358352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cells in connective tissue disorders.
    Sibbitt WL; Bankhurst AD
    Clin Rheum Dis; 1985 Dec; 11(3):507-21. PubMed ID: 3907953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.